About the journal
International Journal of Translational Medicine is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 7 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2673-8937
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 233
- Declared review time
- 7 weeks
- Declared peer-review model
- peer_review
- Official website
- https://www.mdpi.com/journal/ijtm
Index listings
- DOAJ · 2021-12-16
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 7 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
233
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
7weeks
Works in OpenAlex
241
Last recorded publication year
2026
h-index
12
i10-index
16
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2023-04-12
- Added to DOAJ
- 2021-12-16
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918956261306676
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Retinal Diseases and Treatments
- Retinal Diseases and Treatments
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Glaucoma and retinal disorders
- SARS-CoV-2 and COVID-19 Research
- Glaucoma and retinal disorders
Show all subjects (50)
- Retinal Imaging and Analysis
- Retinal Imaging and Analysis
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Liver Disease Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Mesenchymal stem cell research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Immunotherapy and Biomarkers
- COVID-19 Impact on Reproduction
- Liver Disease Diagnosis and Treatment
- COVID-19 Impact on Reproduction
- 3D Printing in Biomedical Research
- Angiogenesis and VEGF in Cancer
- 3D Printing in Biomedical Research
- Mesenchymal stem cell research
- Angiogenesis and VEGF in Cancer
- Lysosomal Storage Disorders Research
- Ubiquitin and proteasome pathways
- MicroRNA in disease regulation
- Genomics and Rare Diseases
- Pluripotent Stem Cells Research
- Cell Adhesion Molecules Research
- Pancreatic and Hepatic Oncology Research
- Pharmacological Effects and Toxicity Studies
- Inflammatory Biomarkers in Disease Prognosis
- Monoclonal and Polyclonal Antibodies Research
- Lysosomal Storage Disorders Research
- Cell Adhesion Molecules Research
- Pancreatic and Hepatic Oncology Research
- Pain Mechanisms and Treatments
- Osteoarthritis Treatment and Mechanisms
- Pain Mechanisms and Treatments
- Osteoarthritis Treatment and Mechanisms
- Peptidase Inhibition and Analysis
- Pharmacological Effects and Toxicity Studies
- Inflammatory Biomarkers in Disease Prognosis
- Genomics and Rare Diseases
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- MicroRNA in disease regulation
Keywords (DOAJ)
- clinical applicability of new biomaterials
- omics science
- biotechnologies
- molecular imaging
- drug discovery and development
- cardiovascular disease
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ